Cargando…
Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer
Immunotherapy, targeted therapy, and adoptive T-cell therapy have been revolutionary advancements in cancer research. Some of these therapies have become the standard of care for lung cancer and replaced older treatment algorithms; some continue to be studied in clinical trials. This article discuss...
Autores principales: | Sepesi, Boris, Cascone, Tina, Chun, Stephen G., Altan, Mehmet, Le, Xiuning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388816/ https://www.ncbi.nlm.nih.gov/pubmed/32883458 http://dx.doi.org/10.1016/j.soc.2020.06.009 |
Ejemplares similares
-
Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer
por: Pradhan, Monika, et al.
Publicado: (2021) -
Current Surgical Indications for Non-Small-Cell Lung Cancer
por: Deboever, Nathaniel, et al.
Publicado: (2022) -
Efficacy of immunotherapy in oncogene-driven non-small-cell lung
cancer
por: Vokes, Natalie I., et al.
Publicado: (2023) -
Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
por: Kumar, Sameera S., et al.
Publicado: (2017) -
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
por: Noh, Ji-Yoon, et al.
Publicado: (2020)